148 related articles for article (PubMed ID: 7634450)
1. HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus.
Syvänne M; Kahri J; Virtanen KS; Taskinen MR
Circulation; 1995 Aug; 92(3):364-70. PubMed ID: 7634450
[TBL] [Abstract][Full Text] [Related]
2. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
[TBL] [Abstract][Full Text] [Related]
3. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein.
Syvänne M; Castro G; Dengremont C; De Geitere C; Jauhiainen M; Ehnholm C; Michelagnoli S; Franceschini G; Kahri J; Taskinen MR
Atherosclerosis; 1996 Dec; 127(2):245-53. PubMed ID: 9125315
[TBL] [Abstract][Full Text] [Related]
4. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease.
O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Holmes D; Kottke BA
Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):228-31. PubMed ID: 7749830
[TBL] [Abstract][Full Text] [Related]
5. Distribution of lipoprotein species (LpA-I, LpA-I:A-II) in serum and HDL subfractions of untrained and trained normolipemic men.
Frey I; Kamps H; Baumstark MW; Berg A; Keul J
Clin Chim Acta; 1992 Oct; 211(3):167-73. PubMed ID: 1458611
[TBL] [Abstract][Full Text] [Related]
6. Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease.
Bakogianni MC; Kalofoutis CA; Skenderi KI; Kalofoutis AT
J Diabetes Complications; 2001; 15(5):265-9. PubMed ID: 11522502
[TBL] [Abstract][Full Text] [Related]
7. Relationship between low-density lipoprotein size and apolipoprotein A-I-containing particles: the ECTIM study.
Luc G; Bard JM; Poulain P; Arveiler D; Evans AE; Cambien F; Fruchart JC; Ducimetière P
Eur J Clin Invest; 1997 Mar; 27(3):242-7. PubMed ID: 9088861
[TBL] [Abstract][Full Text] [Related]
8. HDL subparticles and coronary artery disease in NIDDM.
O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Kottke BA
Atherosclerosis; 1996 Apr; 121(2):285-91. PubMed ID: 9125302
[TBL] [Abstract][Full Text] [Related]
9. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.
Syvänne M; Hilden H; Taskinen MR
J Lipid Res; 1994 Jan; 35(1):15-26. PubMed ID: 8138716
[TBL] [Abstract][Full Text] [Related]
10. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
[TBL] [Abstract][Full Text] [Related]
11. High density lipoprotein subfractions in non-insulin-dependent diabetes mellitus and coronary artery disease.
Syvänne M; Ahola M; Lahdenperä S; Kahri J; Kuusi T; Virtanen KS; Taskinen MR
J Lipid Res; 1995 Mar; 36(3):573-82. PubMed ID: 7775869
[TBL] [Abstract][Full Text] [Related]
12. High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics.
Ji J; Watts GF; Johnson AG; Chan DC; Ooi EM; Rye KA; Serone AP; Barrett PH
J Clin Endocrinol Metab; 2006 Mar; 91(3):973-9. PubMed ID: 16368749
[TBL] [Abstract][Full Text] [Related]
13. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.
Lahdenperä S; Syvänne M; Kahri J; Taskinen MR
Diabetologia; 1996 Apr; 39(4):453-61. PubMed ID: 8777995
[TBL] [Abstract][Full Text] [Related]
14. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
Smuts CM; Weich HF; Weight MJ; Faber M; Kruger M; Lombard CJ; Benadé AJ
Coron Artery Dis; 1994 Apr; 5(4):331-8. PubMed ID: 8044345
[TBL] [Abstract][Full Text] [Related]
15. Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies.
Segrest JP; Cheung MC; Jones MK
J Lipid Res; 2013 Oct; 54(10):2733-44. PubMed ID: 23883582
[TBL] [Abstract][Full Text] [Related]
16. Plasma cholesteryl ester transfer protein activity in non-insulin-dependent diabetic patients with and without coronary artery disease.
Kahri J; Syvänne M; Taskinen MR
Metabolism; 1994 Dec; 43(12):1498-502. PubMed ID: 7990702
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance.
Fruchart JC; Ailhaud G
Clin Chem; 1992 Jun; 38(6):793-7. PubMed ID: 1597003
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein A-I containing lipoproteins in coronary artery disease.
Puchois P; Kandoussi A; Fievet P; Fourrier JL; Bertrand M; Koren E; Fruchart JC
Atherosclerosis; 1987 Nov; 68(1-2):35-40. PubMed ID: 3120739
[TBL] [Abstract][Full Text] [Related]
19. Concentrations of apolipoprotein A-I-containing particles in patients with hypoalphalipoproteinemia.
Montali A; Vega GL; Grundy SM
Arterioscler Thromb; 1994 Apr; 14(4):511-7. PubMed ID: 8148349
[TBL] [Abstract][Full Text] [Related]
20. Distribution of subclasses of HDL containing apoA-I without apoA-II (LpA-I) in normolipidemic men and women.
Duverger N; Rader D; Brewer HB
Arterioscler Thromb; 1994 Oct; 14(10):1594-9. PubMed ID: 7918309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
